Stress/Emotion Management for High Blood Pressure

(OUR-Project Trial)

Recruiting in Palo Alto (17 mi)

Overseen by Kathy D Wright, PhD, RN

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Ohio State University

No Placebo Group

Trial Summary

What is the purpose of this trial?

Covid-19 is an additional stressor Black women have to deal with that may interfere with hypertension self-care management. Social connectedness is a source of resilience for Black women to promote mental and physical health. Unfortunately, in the face of the Covid-19 pandemic, social distancing is a challenge further isolating Black women from their networks. How is social connectedness to manage stress and emotional well-being in a social-distancing society for Black women with hypertension? The research team proposed a synchronous web-based version of Enhanced Co-Created Health Education InterventioN (eCo-CHIN) that build the success and best practices derived from the original intervention. A Covid-19 session will be included as a way of helping Black women to maintain resilience and self-care during stressful times. The eCo-CHIN intervention is innovative and timely because the research team are using a synchronous platform preparing Black women on how to deal with Covid-19 while taking care of self. The primary investigator for this pilot study (Dr. Wright) is a Black Early Stage Investigator and former KL2 (career development) awardee. The interdisciplinary research team has the expertise and resources to deliver this Enhanced Co-CHIN intervention.

Research Team

Kathy D Wright, PhD, RN

Principal Investigator

Assistant Professor

Eligibility Criteria

This trial is for Black/African American women who have high blood pressure, can speak English, and have access to a smartphone or computer with internet. It's not for those with resistant hypertension (blood pressure too high despite using three different meds including a diuretic) or without internet access.

Inclusion Criteria

I have high blood pressure and am managing it with medication or lifestyle changes.

You consider yourself to be Black or African American.

English speaking

Exclusion Criteria

My high blood pressure isn't controlled despite taking three different blood pressure medicines, including a water pill.

No access to computer with internet or smart phone

Treatment Details

Interventions

• Stress and emotion management (Behavioral Intervention)

Trial Overview The study tests an online stress and emotion management program called eCo-CHIN, designed specifically for Black women managing hypertension during the Covid-19 pandemic. It includes sessions on resilience and self-care in times of social distancing.

Participant Groups

Group I: Stress and emotion Management for Black/African Americ Experimental Treatment 1 Intervention

Four weekly sessions delivered in a group format via Zoom teleconference. The following topics are listed in the workbook: Planning Your Information Diet; My Spheres of Influence Worksheet; Practical Wisdom for Tolerating Uncertainty; Reducing Anxiety With Thought Challenging; Reducing Anxiety Through Distraction Activities; Starting a Planning Practice; Starting a Daily Gratitude Practice; Starting a Daily Breathing Practice; Improving the Quality of Your Social Connections; Developing a Regular Exercise Routine; and Creating Your Stress-Resilience Action Plan. Each session will begin with a 15-30 minute check in on what went well, challenges, and Coronavirus Anxiety workbook. The Coronavirus Anxiety Workbook topics are complementary and the sessions will tie together the themes of comprehensive stress and emotional management through blood pressure knowledge/self-monitoring, diet, interpersonal communication skills building, and sleep hygiene.

Who Is Running the Clinical Trial?

Ohio State University

Lead Sponsor

Trials

891

Recruited

2,659,000+

Dr. John J. Warner

Ohio State University

Chief Executive Officer since 2023

MD, MBA

Dr. Peter Mohler

Ohio State University

Chief Medical Officer since 2023

PhD in Molecular Biology